1023-114 Long-term Secondary Prevention After Myocardial Infarction with Amiodarone

Autor: Jerzy Kuch, Edmund Nartowicz, Andrzej Budaj, Janusz Maciejewicz, Wanda Śmielak-Korombel, Piotr Kokowicz, Teresa Zaleska, Leszek Ceremużyński, Maria Krzeminska-Pakula, Andrzej Dyduszyński
Rok vydání: 1995
Předmět:
Zdroj: Journal of the American College of Cardiology. 25(2)
ISSN: 0735-1097
DOI: 10.1016/0735-1097(95)93128-y
Popis: The Polish Amiodarone Trial revealed significant reduction of l-year cardiac mortality with low-dose Amiodarone (Am) after MI. To assess whether this beneficial effect persisted, the long-term outcomes of the pts of the Am treated group (n = 305) and ofthe control group (C) (n = 309) were assessed. The probability of cardiac death after 12 and 46 months according to Kaplan-Meier curves was respectively Am 6.2,17.4% and C 10.7, 19.5%. The curves after 12 months remained parallel. The comparison of 25 pts treated continuosly for 46 months with Am and 189 C pts not treated with Am revealed significant difference in survival curves in favour of Am treated group (p = 0.04). Side effects occurred in 3 of 25 pts treated with Am during long-term follow-up. Beneficial effect of one year Am treatment on survival after Mi persists for the next three years. The prolongation of therapy is feasible and diminishes the risk of cardiac death.
Databáze: OpenAIRE